| Discovery Informatics |
|
| Jubilant Biosys Discovery Informatics team helps its customers with a wide array of Informatics services that would cut down on the time spent on research data processing. Rather, these services allow customers to focus on research. |
|
| Our Informatics services and solutions are aimed to solve the data challenges that arise at each stage of drug discovery. Jubilant informatics team has a large pool of qualified professionals with high level of proficiency in technology platforms and leverages Jubilant’s vast experience in Pharma and Life Science industry to offer innovative solutions across many therapeutic and disease areas. |
|
| Jubilant Discovery informatics offers following services:
|
|
| Custom curation services |
| Jubilant Biosys employs a proven methodology to create content databases curated from various data sources as per the customer specification. These content bases are manually curated by M.S/PhD level scientists guided through defined Good Curation Practice (GCP), controlled vocabulary and ontology. Jubilant’s custom curation services cover Biology, Chemistry and Clinical Trial domains across many therapeutic and disease areas. Our curation scientists have meticulous understanding of various public domain data sources and can create valuable knowledge platforms by integrating both public domain data sets and client’s proprietary research data. Our content curation expertise is further augmented by business intelligence and technology platforms development for advanced data analysis. |
| Top |
|
| Genome data analysis |
Jubilant Biosys offers its customers end-to-end genome data analysis services to address one of the most obvious challenges faced by pharma industry today. Our genome services ranges from sequence annotation to functional mapping and are characterized by our proficiency in cutting edge tools and our vast experience in processing R&D data. Jubilant’s genome analysis capabilities are well supported by its proprietary Discovery Informatics Gateway (DIG) platform which comprises pathway, biomarker and small molecule databases as they extensively cover various cancer types providing Jubilant an edge in annotations.
Services offered:
- Microarray analysis
- Next Generation Sequencing(NGS) - CHiP- Sequence, RNA-Sequence
- Functional Mapping: Genome to Pathway
|
| Top |
|
| Target Intelligence and Analytics |
| Target discovery is made simpler with Jubilant’s target analytic reports generated from its proprietary Discovery Informatics Gateway (DIG) platform and custom curation of data from patents, journal articles and clinical reports. DIG combines various data sources covering pathways, biomarkers, small molecule modulators, clinical trials and drugs to provide holistic information for any specific target. Jubilant’s target reports are tailor made to suit customer specifications and saves lot of scientist’s time in their target research. |
| Top |
|
| Clinical Trial Intelligence |
Jubilant Biosys clinical trial intelligence services offer tailor made data intelligence and analytical solutions under following categories:
- Clinical trial intelligence
- Key Opinion Leader (KOL) assessment
- Health technology assessment
- Formularies and payer intelligence
- Clinical biomarkers
- Drug repositioning strategy intelligence
- Disease-area pipeline benchmarking intelligence
|
| Top |
|
| Commercial Products |
Jubilant Biosys offers ready to use database packages and customizable decision support systems to suit customer specific requirements.
Products offered:
- PathArt™ - Pathway database
A database of manually curated biomolecular interactions with specific focus on signaling and metabolic pathways in disease conditions. PathArt™ has a collection of more than 3000 high priority pathways covered.
- Molsign™ - Biomarker database
A manually curated disease centric Biomarker database, information captured for around 9000 biomarkers spanning 3 major diseases – Cancer, Arthritis and Diabetes.
- Chembiobase™- Small molecule database
A comprehensive set of target centric ligand databases of small molecules with activity against targets and target families. Chembiobase™ has a collection of more than 2 million molecules and their properties covered.
|
| Top |
|
| Pharma IT services |
At Jubilant Biosys, integrating technology into drug discovery process is a natural extension of our strength in informatics services. Our unique advantage is derived from the highly integrated nature of our scientific and technology teams. From building novel automation platforms and large-scale data acquisition & analysis systems to advanced solutions for clinical data, Jubilant offers IT solutions that span the entire drug discovery R&D process and present scientists with decision making systems to reduce the R&D time.
Services offered:
- R&D analytical tools development
- LIMS development and customization
- System validation services
|
| Top |
|
|
|
